Altamira Therapeutics Ltd.: xbrl:AccountingProfit

Value	`{"amount": -4417386, "currency": "USD"}`
Period	2023-01-01 – 2023-12-31
Status	current
Entity	Altamira Therapeutics Ltd.

Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/cde416a5-7593-4790-90ea-8577a45db81d

History

supersedes {"amount": -3969020, "currency": "USD"} (evidence 0001213900-24-034940)